Cook Medical has claimed that its new endoscopic injection device Injekt VUR Injection Needle is an alternative to corrective surgery in advanced treatment of vesicoureteral reflux (VUR). It provides urologists a controlled, precised and accurate treatment of urinary tract condition in infants and young children.
Cook Medical said that the Injekt VUR Injection Needle can be used in either of the two endoscopic treatment methods like subureteric transurethral injection (STING) or hydrodistention implantation technique (HIT) for treating VUR.
The injection therapy, advanced over traditional methods, is an outpatient procedure that typically takes 15 to 20 minutes and may result in correction rates up to 86% unlike surgical repair.
The feature of etch markings on the Injekt’s filiform tip helps to aid in precise placement of the bulking agent on the injection, minimizing both the amount of time required for the procedure and the amount of agent needed for effective treatment.
Nicky James, vice president and global business leader of Urology division at Cook Medical, said: “Cook Medical is dedicated to the development and delivery of new medical technologies such as the Injekt VUR Injection Needle to improve patient outcomes and control the costs of treatment. Injekt enables a physician to treat pediatric patients with a minimally-invasive treatment option that ideally decrease the costs related to surgery or long-term treatment with antibiotics.”